Can serum periostin predict bronchopulmonary dysplasia in premature infants?
Can serum periostin predict bronchopulmonary dysplasia in premature infants?
About this item
Full title
Author / Creator
Go, Hayato , Ono, Junya , Ohto, Hitoshi , Nollet, Kenneth E. , Sato, Kenichi , Kume, Yohei , Maeda, Hajime , Chishiki, Mina , Haneda, Kentaro , Ichikawa, Hirotaka , Kashiwabara, Nozomi , Kanai, Yuji , Ogasawara, Kei , Sato, Maki , Hashimoto, Koichi , Nunomura, Satoshi , Izuhara, Kenji and Hosoya, Mitsuaki
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
Background
Bronchopulmonary dysplasia (BPD) is the most common morbidity complicating preterm birth and affects long-term respiratory outcomes. The objectives of this study were to establish whether serum periostin at birth, day of life (DOL) 28, and corrected 36 weeks’ gestational age could be potential biomarkers for BPD.
Methods
A total...
Alternative Titles
Full title
Can serum periostin predict bronchopulmonary dysplasia in premature infants?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2615110172
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2615110172
Other Identifiers
ISSN
0031-3998
E-ISSN
1530-0447
DOI
10.1038/s41390-021-01912-w
